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ABSTRACT
Objective: to evaluate the effectiveness of an educational nursing intervention to reduce hyperphosphataemia in chronic 
renal patients on hemodialysis. Method: quasi-experimental study with 63 hyperphosphatemic patients on hemodialysis. The 
intervention consisted of developing and providing a printed and illustrated manual to patients containing information on 
disease control. The participant was asked to complete a daily checklist with the aim to reinforce aspects provided in the manual. 
Laboratory tests and itching intensity were analyzed at the beginning of the study, and at 30 and 60 days after the educational 
intervention. Results: the mean age of participants was 58±13.1 years, with a treatment time of 51.1±44.7 months. A reduction 
in serum phosphorus values of 7.06 ± 1.43 to 5.80 ± 1.53 (p <0.001) and the intensity of itching after the intervention was 
observed. Conclusion: the educational nursing intervention was effective in reducing phosphate and decreasing itching in 
hyperphosphatemic patients. 
Descriptors: Renal Dialysis; Hyperphosphataemia; Nursing; Hemodialysis; Renal Insuffi ciency, Chronic.
RESUMO
Objetivo: avaliar a efetividade de uma intervenção educacional de enfermagem para redução da hiperfosfatemia em pacientes 
renais crônicos em hemodiálise. Método: estudo quase experimental realizado com 63 pacientes hiperfosfatêmicos em 
hemodiálise. A intervenção se constituiu em orientar e disponibilizar um manual impresso e ilustrado aos pacientes, contendo 
informações sobre o controle da doença. Foi solicitado o preenchimento de um checklist diário, com fi nalidade recordatória 
dos aspectos abordados no manual. Os exames laboratoriais e a intensidade do prurido foram analisados no início do estudo, 
aos 30 e 60 dias após a intervenção educacional. Resultados: a média de idade dos participantes foi 58±13,1 anos e tempo de 
tratamento de 51,1±44,7 meses. Houve redução dos valores séricos do fósforo de 7,06±1,43 para 5,80±1,53 (p<0,001) e da 
intensidade do prurido após a intervenção. Conclusão: a Intervenção Educacional de Enfermagem foi efetiva para redução do 
fosfato e diminuição do prurido nos pacientes hiperfosfatêmicos.
Descritores: Diálise Renal; Hiperfosfatemia; Enfermagem; Hemodiálise; Insufi ciência Renal Crônica.
RESEARCH
Educational nursing intervention to reduce the 
hyperphosphatemia in patients on hemodialysis 
Intervenção educacional de enfermagem para redução da hiperfosfatemia em pacientes em hemodiálise
Intervención educativa de enfermería para reducir hiperfosfatemia en pacientes en hemodiálisis
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INTRODUCTION
Chronic kidney disease (CKD) occurs in 5-10% of the popula-
tion and has gradually increased in Brazil, which may be associ-
ated with the increased percentage of individuals diagnosed with 
diabetes and hypertension(1). The number of patients on dialysis 
programs in Brazil has increased significantly, from 42,695 pa-
tients in 2000, to 92,091 in 2010, and 112,004 in 2014, rep-
resenting an increase of 20,000 patients in the last four years (2). 
Data from the Brazilian Chronic Dialysis Census, 2014, showed 
an increase in the prevalence rate of dialysis treatment in relation 
to 2013, and a growth in the incidence rate(2). These data are also 
associated with longevity of the population and quality of life(1-3). 
Most chronic renal patients on hemodialysis develop hyper-
phosphataemia, resulting from excessive phosphorus (P) intake, 
reduced P clearance, and conditions of bone remodeling(4). 
The increase in P in the chronic kidney patient is related to a 
high risk of cardiovascular disease, secondary hyperparathy-
roidism, and reduced production of calcitriol(3). Furthermore, 
changes in the calcium and phosphate metabolism contribute 
to an increased risk of mortality in this population(5-6). Fibroblast 
growth factor 23 (FGF-23), discovered more than ten years ago, 
has among its functions the inhibition of 1α-hydroxylase, the 
enzyme responsible for calcitriol synthesis(7). This finding led to 
a new understanding about phosphorus control mechanisms as-
sociated with mortality in chronic renal failure patients(7).
In the early stage of CKD, renal adaptation occurs, charac-
terized by a decrease in tubular reabsorption of phosphorus 
and increased phosphaturia in the remaining nephrons. This 
process is maintained by increased levels of the parathyroid 
hormone (PTH)(6). With the gradual decline of the glomeru-
lar filtration rate (GFR), this compensatory mechanism fails to 
maintain the phosphate levels within the normal range. The 
consequences of hyperphosphatemia occur, such as:  sec-
ondary hyperparathyroidism, metastatic calcifications, cystic 
fibrous osteitis, as well as its contribution to the progression 
of renal failure, significant morbidity due to pain, osteopenia, 
increased risk of fractures, anemia, hypertension, atheroscle-
rotic vascular disease, pruritus, and sexual dysfunction(6).
The dialytic methods are very effective for removal of se-
rum phosphorus, while adherence to the controlled diet is 
difficult, which makes use of phosphate binders essential for 
hyperphosphatemic patients. There is a lack of programs to evalu-
ate food intake, such as the addition of phosphorus in food, that is 
not considered to be a problem, as the bioavailability of it is great-
er(8). Chelating agents promote the reduction of serum phospho-
rus absorption by binding to phosphorus in food in the intestine(4). 
The role of their chelators on the FGF-23 levels and its clinical 
impact on mortality and progression of CKD require randomized, 
controlled studies, with a significant number of patients(7). 
The guidelines of the Kidney Disease Improving Global Out-
comes (KDIGO) and Kidney Disease Outcomes Quality Initia-
tive (KDOQI) recommend the use of phosphate binders for hy-
perphosphatemic patients in all stages of ESRD(5-6). The chelator 
of choice must be individualized; all available types on the mar-
ket are effective in reducing the serum phosphorus. There is a 
lack of evidence on the effects of each chelator class on morbid-
ity and mortality, vascular calcification, and bone disease(5-6,9).
In a randomized study comparing sevelamer and calcium-
chelation agent, the authors affirm that high serum phospho-
rus and calcium are associated with arterial calcification and 
mortality in patients on dialysis(10). In elderly individuals over 
65 years of age, a significant effect of sevelamer on reducing 
mortality was identified(10). The KDIGO recommends against 
using aluminum-based chelators(6) to prevent metal poisoning. 
Phosphorus dietary restriction is important and does not affect 
the nutritional status of patients, but new evidence demon-
strating the impact of interventions on clinical outcomes are 
not available. Meanwhile, the KDIGO guidelines do not rec-
ommend specific values for daily phosphorus intake, however 
the KDOQI recommended daily phosphorus intake of 800 
mg, which is similar to the Brazilian guideline(9,11-12).
In a study that analyzed the impact of an educational inter-
vention for controlling bone disorder markers, adherence to the 
use of chelating medications, and knowledge about such medica-
tions, showed that there were no statistically significant changes 
in clinical markers, but a significant improvement in the propor-
tion of patients who joined the chelating treatment, from 44% to 
72% (p=0.016), and an expanded knowledge of the medicinal 
product(13). These results report the relevance of the nurse’s role 
as a health educator, in order to empower patients to increase 
knowledge and improve the adherence to treatment.
In this context, the lack of adherence to one or more aspects 
of hemodialysis treatment is a constant concern of the healthcare 
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RESUMEN
Objetivo: evaluar la eficacia de una intervención educativa de enfermería para reducir hiperfosfatemia en pacientes con 
insuficiencia renal crónica en hemodiálisis. Método: estudio cuasi-experimental con 63 pacientes en hemodiálisis con 
hiperfosfatemia. La intervención consistió en guiar los pacientes y proporcionar un manual impreso e ilustrado con informaciones 
sobre el control de la enfermedad. Se solicitó completar una lista de verificación todos los días con el propósito de recordar los 
aspectos tratados en el manual. Se analizaron las pruebas de laboratorio y la intensidad del picor al inicio del estudio, 30 y 60 
días después de la intervención educativa. Resultados: la edad promedio de los participantes fue 58±13,1 años y el tiempo de 
tratamiento fue 51,1±44,7 meses. Hubo reducción de los valores séricos de fósforo de 7,06±1,43 para 5,80±1,53 (p<0,001) 
y de la intensidad del picor después de la intervención. Conclusión: la intervención educativa de enfermería fue eficaz en la 
reducción de fosfato y disminución del picor en pacientes con hiperfosfatemia.
Descriptores: Diálisis Renal, Hiperfosfatemia, Enfermería, Diálisis Renal, Insuficiencia Renal Crónica.
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team in nephrology, as it may increase morbidity and mortality, 
and thereby compromise the quality of life of chronic renal pa-
tients(14). Itching  is among the clinical conditions secondary to hy-
perphosphatemia that impact the quality of life of these patients.
The etiology of itching is related to xerosis, secondary hy-
perparathyroidism, high serum phosphate and magnesium, 
among others. Dialysis has an insignificant impact on the im-
provement of itching, which contributes to an important ther-
apeutic challenge(15). Thus, the healthcare professionals who 
deal with these patients  need the knowledge of these mani-
festations, aiming at early detection, proper management and 
cooperation with investigations that contribute to clarify the 
pathophysiology, thereby establishing effective treatments for 
resolving these conditions. In this context, the treatment of hy-
perphosphatemia has better results if is sustained by the triad: 
use of chelation, proper diet, and adherence to treatment(15-17).
This triad can be made possible by the nurse’s performance 
in educational actions. The educational nursing intervention 
provides the patient approach in order to establish communica-
tion and relationship, as well as to facilitate understanding about 
the disease, enabling a greater adherence to treatment. The in-
tervention may be constituted by printed information such as 
educational materials, personalized or group guidance, in order 
to provide the individual with skills for self-care, such as the 
subject of their treatment,(18) reducing the morbidity related to 
the disease, and improving the quality of life of this population. 
Considering the above, this study can contribute positively 
to the quality of care to patients with renal failure.  Educational 
intervention can mobilize patients for treatment adherence, 
enabling greater knowledge about the disease, hyperphospha-
temia treatment, and decreasing complications, morbidity and 
mortality, and can improve the assessment of their quality of life.
OBJECTIVE 
To evaluate the effectiveness of a nursing educational inter-
vention (NEI) for reduction of hyperphosphatemia in chronic 
renal patients on hemodialysis.
METHOD
Ethical aspects
The chronic renal failure patients on hemodialysis were 
consulted about their availability to participate in the study, 
and were informed about the study objectives as well as the 
confidentiality of their identity. All participants signed the 
Terms of Free and Informed Consent form in duplicate, with 
one given to the respondent and the other remaining with the 
researcher, in accordance with Resolution No. 196/96 . The 
study was preceded by the approval of the Ethics Committee 
of the Federal University of São Paulo.
Design, site and study period 
This was a quasi-experimental study, of a before and after 
design, conducted during the period from 2011 to 2014, in a 
renal dialysis unit of the interior of Rio Grande do Sul, which 
provided care for an average of 110 patients per month.
Sample
The study included 63 chronic renal failure patients who 
met the inclusion criteria, which were: receiving hemodialysis 
three times a week, for a period of four hours; mean serum 
phosphorus above 5.5 mg/ dL in the last six months, and liter-
ate. Patients who had difficulty understanding the guidelines 
for disease control, explained in the manual, were excluded.
Study protocol
Data were collected using a study protocol composed of a 
clinical, laboratory and socio-demographic characteristics form. 
This information was collected directly from patient records.
For implementation of the educational nursing intervention, a 
manual with ten domains for patients with hyperphosphataemia 
was used, developed as recommended by Echert(19) according 
to the Ordinance of the Health Care Department/MS No. 225 
-  May 10, 2010 (20), which includes the Protocol and Therapeu-
tic Guidelines - Hyperphosphatemia in Chronic Renal failure. 
The manual includes guidelines, in a language accessible by 
patients, about CKD, hyperphosphatemia, signs and symptoms, 
treatment, phosphate binder use, dietary care, benefits, risks and 
options for improving health-related quality of life(18).
A checklist was developed consisting of 16 explicative ques-
tions about the manual for the patient to record his/her daily 
actions of care and morbidity control. Of the 16 questions, 13 
were dichotomous, “yes or no”, which denoted the understand-
ing and comprehension about the explicit content of the manu-
al. Question 14 refers to the daily record of the itching intensity, 
using a Likert scale; considered the following scores in a Likert 
scale (1-None; 2-Little, 3-More or less; 4 – Much, and 5 - Very 
much). Question 15 was answered by the researcher at the end 
of the intervention, referring to attending hemodialysis sessions 
for medical and nursing guidance, and the question 16 assessed 
the positive attitude towards the disease, treatment adherence, 
and perceptions of confronting the health-related quality of life. 
The manual content and checklist were validated for internal 
consistency by nurses and later by 21 patients(18).
The  manual and checklist content validation was conducted 
in two phases: the first consisted of the validation by nurses and 
the second by patients, using the Delphi technique. The draft 
manual and the checklist was presented to seven nurses, experts 
in nephrology, who made minor suggestions in the text. Once con-
sensus was obtained, the final version was redesigned and in the 
second phase it was validated by 21 patients, cared for in a kid-
ney unit of a general hospital. At this stage, the patients reported if 
the checklist represented the content of the manual and whether 
the questions were understood, answering “yes or no”. Next, the 
Cronbach’s alpha test was performed to verify the understanding 
of patients related to the manual information and the checklist(18).
The study protocol was applied to the patients who met the 
inclusion criteria. The educational nursing intervention consisted 
of individual guidance to participants on the aspects of the print-
ed and illustrated manual. The laboratory tests used for analysis 
were those from the month in which the patient was included 
in the study, prior to undergoing the intervention (pre), values 
from 30 days after the beginning of the study, and from 60 days 
after the intervention (post). The laboratory tests assessed were: 
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phosphorus, calcium, potassium, hematocrit, hemoglobin, alka-
line phosphatase, parathyroid hormone, and urea removal index 
(Kt/V), the main indicator of hemodialysis adequacy(21).
Data analysis 
Data were analyzed using descriptive statistics, using the 
Statistical Package for the Social Sciences (SPSS), version 
15.0. The difference between the means of laboratory results 
of hyperphosphatemic patients was verified using the ANO-
VA, Tukey test, and Student’s t-test. The relationship between 
the itching intensity reported by the patients was analyzed 
with the Pearson correlation test.
RESULTS 
Table 1 presents the sociodemographic and clinical data of 
63 hyperphosphatemic patients included in the study. 
It was found that 66.7% of patients were male, 63.5% were 
married, with a mean age of 58.8 ± 13.1 years. The level of 
education, measured by years of study, had a median of five 
years. For 80.9% of patients, income was derived from retire-
ment. The most common causes of CKD were systemic arterial 
hypertension (SAH), diabetes mellitus (DM) or undetermined 
cause. For calculation of time living with CKD, the median 
and 25th and 75th percentiles was used; 25% of patients had 
the diagnosis less than two years, 50% within five years, and 
75% less than ten years. Time on hemodialysis showed that 
25% of patients began treatment within the past 18 months, 
50% within 36 months, and 75% less than 72 months.
Table 2 shows the results of laboratory tests of hyperphos-
phatemic patients.
A statistically significant re-
duction in the mean creatinine 
and phosphorus was identi-
fied, at the beginning and 30 
days after completion of the ed-
ucational nursing intervention 
(p <0.001) but after 60 days, 
an increase in the phosphorus 
mean values was identified in 
relation to the assessment con-
ducted at 30 days.  The com-
parative analysis between the 
mean values obtained at 30 
and 60 days showed no reduc-
tion [5.80 (±1.53) versus 6.51 
(±1.74)], although it remained 
below the initial values[7.06 
(± 1.43)].
The analysis of the creati-
nine values, at 30 and 60 days 
after the intervention, showed 
reductions that were statisti-
cally significant differences 
[11.22 (± 3.10) 8.95 (2.37 ±) 
and 8.61 (± 2.25), p 0.001], 
respectively.  
Table 1 – Sociodemographic and clinical data of hyper-
phosphatemic patients on hemodialysis, Ijuí, Rio 
Grande do Sul, Brazil, 2013
Characteristics n (%)
Sex
Male 42(66.7)
Female 21(33.3)
Age* 58.87±13.12
Marital status
Married 40(63.5)
Single 10(15.9)
Divorced/separated 5(7.9)
Widowed 8(12.7)
Education (years of study)** (4;5;7)
Income
Retirement 51(80.9)
Others 12(19.0)
Cause of the kidney disease  
Systemic arterial hypertension 22(34.9)
Undetermined cause 18(28.6)
Diabetes mellitus 10 (15.9)
Systemic arterial hypertension + Diabetes mellitus 7 (11.1)
Other 6 (9.5)
Time treating chronic kidney disease (years)** (2;5;10)
Time in  hemodialysis (months)** (18;36;72)
Note: * mean ± standard deviation **(Percentile 25; Median; Percentile 75)
Table 2 – Results of laboratory tests of hyperphosphatemic patients, 30 and 60 days after 
the educational intervention in nursing, Ijuí, Rio Grande do Sul, Brazil, 2013
Beginning 30 days 60 days p value
Test Mean ± SD Mean ± SD Mean ± SD (ANOVA)
Urea (mg/dl) 171.84 ±47.92 177.16 ±40.59 164.60 ±35.94 >0.05
Creatinine (mg/dl) 11.22 ±3.10* 8.95 ±2.37* 8.61 ±2.25* <0.001
Calcium (mg/dl) 9.33 ±1.34* 9.55 ±1.33* 10.57 ±1.66* <0.001
Phosphorus ( (mg/dl) 7.06 ±1.43* 5.80 ±1.53* 6.51 ±1.74** <0.001
Potassium (mEq/l) 5.70 ±1.04 5.38 ±1.07 5.39 ±0.89 >0.05
Hematocrit (%) 32.96 ±6.68 33.67 ±7.29 33.28 ±7.99 >0.05
Hemoglobin (g/dl) 10.78 ±2.10 10.79 ±2.20 10.93 ±2.19 >0.05
Urea removal index 1.43±0.18 1.41±0.15 1.42±0.19 >0.05
Alkaline Phosphatase (ui/l) 144.08±65.01 153.68±85.51 >0.05 (Teste t)
Parathyroid hormone (pg/ml)*** 465.78±524.17 519.51±621.81 <0.05 (Teste t)
Note: SD = Standard Deviation; significant difference between the mean - determined by ANOVA; * p <0.05 sig-
nificant difference between the mean (Tukey test): Creatinine mean beginning, after 30 and 60 days; Calcium mean 
beginning, after 60 days between 30 and 60 days; Phosphorus mean beginning, after 30 days; ** p <0.001 significant 
difference between the mean Phosphorus in draws after 30 and 60 days - determined by the Tukey test; p <0.05 sig-
nificant difference between the mean PTH at the beginning and end of the NEI - ascertained using Student’s t-test; *** 
p <0.05 significant difference between the mean (Tukey test); ** p <0.001 significant difference between the mean 
Phosphorus (Tukey test); *** p <0.05 significant difference between the mean PTH at the beginning and end of the 
NEI (Student t-test).
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5
4
3
2
1
0
-1
Beginning First 30 days
LL M-SD M M+SD UL
1.95±(1.26) 1.94±(1.02) 1.80±(0.86)
Last 30 days
Note: Scores: 1-None; 2-Little; 3-More or less; 4-Much; 5-Very much; Mean ± 
standard deviation: Beginning-1.95±1.26; First 30 days-1.94 ± 1.02; Last 30 
days, 1.80 ± 0.86; Significant correlation (p <0.001): Beginning and first 30 
days (r = 0.77); the first 30 days and after 60 days (r = 0.79); beginning and 
after 60 days (r = 0.55).
Figure 1 – Daily assessment of itching at the beginning, af-
ter the first 30 days, and after 60 days of nursing 
educational intervention, Ijuí, Rio Grande do Sul, 
Brazil, 2013
Hypertension (34.9 %) was the most often associated disease 
with CKD,  results similar to the Brazilian Chronic Dialysis 
Census(2) and a study conducted with 33 hyperphosphatemic 
patients on hemodialysis(21).
As hemodialysis is an invasive treatment modality that re-
quires specialized care, high economic costs, demand and 
implies physical and psychosocial debilitation for both pa-
tients and family, nurses must know the profile of the chronic 
kidney patient receiving care, in order to appropriately inter-
vene. Because of their close and continuous contact with the 
patient and their responsibility for the care, nurses constitute 
an axis that includes a series of actions, such as comprehen-
sive care and health education, involving both the team of 
professionals and family caregivers(23). 
This study identified a significant reduction in the serum 
levels of creatinine and phosphorus, at the beginning and 
after 30 days of nursing educational intervention, showing 
this intervention was effective. When comparing the means 
of serum phosphorus levels at the beginning and after 60 
days of intervention, the reduction in levels was statistically 
significant; the mean values remained lower than before the 
intervention.
A multicenter study of Stockholm, showed that the hyper-
phosphatemic patients who had participated in a continuous 
educational program on the balance of calcium and phos-
phate, had a significant decrease in their phosphate mean 
plasma after the intervention (2.14 to 1.87 mmol, p <0.05) 
and remained low over time, 1.78 mmol/l at 12 months of 
follow-up (p <0.001)(22). In addition, the authors showed 
that the patients’ knowledge about food intake, calcium/
phosphate balance, and use of phosphate binders increased 
significantly after the educational intervention (p<0.001)(22). 
These results show the effectiveness of a structured educa-
tion program and reinforce the need for it to be included in 
the educational interventions assistance for a better adher-
ence to treatment and better clinical outcomes.
In this context, the continuity of home care requires nurs-
ing instructions for the patient and family, related to difficul-
ties in dealing with the disease and its economic, emotional 
and social consequences(23). These individuals require a set of 
knowledge to adhere to therapy and, in addition, a support 
strategy that provides mechanisms to handle the difficulties of 
the disease. In this regard, the role of nurses as health educa-
tors is to maintain effective communication with patients and 
families and to develop interventions that increase knowledge 
and promote behavior changes that are reflected in clinical 
and laboratory results, and quality of life.
Results of a cohort study conducted with 33 patients, ran-
domized to two groups, that evaluated effects of a teaching-
learning program on metabolism and control of serum cal-
cium (Ca), phosphorus (PO4), parathyroid hormone, Ca/PO4 
product, indicated that a short-term program did not produce 
significant changes in behavior, measured by biochemical 
parameters(21). This evidence demonstrate that, in order to be 
effective, programs of this type must be permanent and inter-
disciplinary, aiming at behavioral changes and adherence to 
dietary and pharmacological measures.
A statistically significant increase of serum calcium levels 
was identified within the mean  beginning of the IEE, 30 and 
60 days after [9.33 (± 1.34), 9.55 (± 1.33), 10.57 (± 1.66); p 
= 0.001], respectively. No statistically significant differences 
were found between the means of urea, potassium, hemoglo-
bin, hematocrit, urea removal index, alkaline phosphatase. 
The  PTH showed an increase with a statistically significant 
difference [465.78 (± 524.17) versus 519.51 (± 621.81), p 
<0.05] in the measurements obtained at the beginning and 
after 60 days of nursing educational intervention.
Figure 1 shows the mean (± SD) scores of daily evalua-
tion of itching at the beginning, at 30 days and 60 days after 
the nursing educational intervention. A decrease was ob-
served in the mean and standard deviation scores obtained 
in these períods (1.95 (± 1.26); 1.94 (± 1.02) and 1.80 (± 
0.86), respectively). There was a significant correlation (p 
<0.01) between the beginning and the first 30 days after 
intervention (r = 0.77) between the first 30 days and after 60 
days (r = 0.79) and between the beginning and after 60 days 
of intervention (r = 0.55).
DISCUSSION 
The population of hyperphosphatemic patients had a pre-
dominance of male retirees, with a mean age of 58.87 years, 
with a low level of education. The median of CKD diagnosis 
was five years, and the median time on hemodialysis was 36 
months. These results are similar to a multicenter study con-
ducted with 43 patients treated in nine hyperphosphatemic 
renal clinics of Stockholm, Sweden, whose patients showed a 
mean age of 60.7 years, 70% had finished elementary school, 
and 88% had a mean of 31 months on hemodialysis(22). 
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In this context, an ethnographic approach studying nurses 
on a hemodialysis unit in Mexico, showed the needs and 
challenges of coordinated care between hospital and home 
on the care of renal patients on hemodialysis(23). The results 
demonstrated needs and challenges faced by nurses in the 
care of chronic kidney disease, and identified barriers, such 
as work overload and lack of a systematic strategy for educa-
tion and lifelong orientation of patients, families and caregiv-
ers(23). In a similar way, this study demonstrates the impor-
tance of and need for a multidisciplinary strategy beyond the 
provision of conventional guidance, to ensure coordinated 
hospital-home care, in order to increase adherence to thera-
py, the effectiveness of substitution therapy, and the quality 
of life of the patient.
The increase in serum calcium levels was statistically sig-
nificant between the means (p <0.001), comparing the begin-
ning of the intervention and 60 days after, and within the 30 
and 60 days after the completion of the nursing educational 
intervention, different from the Stockholm study results(22). 
The cited study did not show significant differences between 
the means of urea, potassium, hemoglobin, and hematocrit 
during these different periods of the intervention.
The Removal Index Urea (Kt/V) is the main indicator of he-
modialysis adequacy. In this study, no statistically significant 
difference in Kt/V was identified, when compared to the value 
obtained at the beginning (1.43), 30 days post-intervention 
(1.41), and at the end of the study (1.42). This data corrobo-
rates the hypothesis that the nursing educational intervention 
was effective in reducing the phosphorus, calcium elevation 
and decreased itching, regardless of the Kt/V.
In the analysis of the mean score of the daily itching as-
sessment reported by hyperphosphatemic patients, there was 
a strong and statistically significant (p<0.001) correlation in 
itching reduction in the three stages, at the beginning, 30 days 
and 60 days after the nursing educational intervention. Thus, 
it can be said that the intervention was effective in reducing 
hyperphosphatemia and that the more informed patients are 
about their disease and treatment, the better their treatment 
adherence, which may have a possible impact of reduc-
ing morbidity and mortality, and improving quality of life of 
chronic renal patients.
In an action-research developed by nurse educators, the 
teaching-learning processes were used, with training for self-
care and empowerment of older people in two locations(24). 
Educational sessions were followed by reflective meetings, 
and the results showed different educational interests present 
together with the need for dialogue as a reference for par-
ticipants and nurses. The authors highlighted the relevance of 
adopting epistemological positions that contribute to greater 
autonomy, aiming for dialogical learning in health(24).
According to the data presented, the performing of edu-
cational interventions and the improvement of adherence 
to treatment in chronic renal failure is a major challenge for 
the multidisciplinary team, because when this process is per-
formed in an ongoing way,  the results are effective. Different 
studies show that among all of the health professionals who 
care for dialysis patients, nurses are ideally placed to influ-
ence change because of their continuous contact in each 
session(13,25-26). In particular, this study demonstrates the effec-
tiveness of an individualized, patient-centered nursing edu-
cational intervention, which can be more successful than a 
“one size fits all” Approach. Thus, the manual and individual 
monthly checklist are positive elements that can be used by 
nurses working in nephrology, with positive results in patient 
adherence to the treatment of hyperphosphatemia and reduc-
tion in the harm caused in the patient’s life.
Study limmitations
The sample size,  the lack of a control group, and the fact 
that the educational nursing intervention was used only once 
with the patient, rather than continuously, can be considered 
limitations of this study, which may possibly have contribut-
ed to the slight elevation of the phosphorus between 30 and 
60 days after intervention. Even though nurses are well posi-
tioned to influence the adherence to treatment, the inclusion 
of every healthcare professional, led by a researcher,  could 
maximize educational intervention.
Contributions to nursing care 
This research refers to an expansion of knowledge for nurs-
ing as a science, regarding the expansion of evidence, with 
emphasis on the use of an educational intervention to empow-
er the chronic renal patient and thus make him the subject of 
treatment. The results of this research can also be important 
both for nurses and for the other healthcare team members 
who work in the care of chronic kidney patient, in order to re-
flect, discuss and implement educational actions to qualify the 
care for this significant percentage of the population, which 
requires specific treatment for sustaining life with quality.
CONCLUSION 
The results of this study demonstrate the importance of es-
tablishing educational interventions with hyperphosphatemic 
chronic renal patients on hemodialysis, aiming for the realiza-
tion of a nursing educational intervention,  in reducing the 
serum phosphate levels, creatinine and itching reduction .
As the nurse is the professional who manages the team re-
sponsible for patient care in a kidney unit, the nursing edu-
cational intervention should be considered an essential tool 
for successful treatment. In addition, the nurse continuously 
interacts with the patients and their families, which favors the 
realization of educational activities to elucidate aspects of the 
disease and alternatives to reduce damage to health and better 
coping with chronic illness.
Thus, the nursing educational intervention was effective in 
reducing hyperphosphatemia, and the more informed patients 
were about their disease and treatment, the better their adherence 
to treatment, which possibly will impact quality of life, reducing 
the high morbidity and mortality affecting this population.
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